Uterine Polyps for USMLE Step 2

Uterine Polyps for the USMLE Step 2 Exam
Definition and Pathophysiology
  • Definition
    • Uterine polyps are benign overgrowths of endometrial tissue that project into the uterine cavity. These growths are composed of endometrial glands, stroma, and blood vessels.
    • Polyps can be single or multiple and vary in size from a few millimeters to several centimeters. They may be either pedunculated (on a stalk) or sessile (flat-based).
uterine polyps
  • Pathophysiology
    • Arise from localized hyperplasia of endometrial glands and stroma, influenced by estrogen, which stimulates endometrial proliferation.
    • Genetic mutations, such as in PTEN and beta-catenin pathways, may play a role in their development, leading to excessive cellular growth.
Risk Factors
  • Age: Polyps are more common in perimenopausal and postmenopausal women, typically between ages 40-50.
  • Estrogen Exposure: Unopposed estrogen or tamoxifen use (a selective estrogen receptor modulator) increases the risk due to its partial agonist effect on endometrial tissue.
  • Obesity: Excess adipose tissue leads to peripheral conversion of androgens to estrogen, raising the risk.
  • Hypertension: Some studies suggest a link between hypertension and endometrial polyp formation.
Clinical Manifestations
  • Abnormal Uterine Bleeding (AUB):
    • The most common symptom, presenting as intermenstrual bleeding, menorrhagia (heavy menstrual bleeding), or postmenopausal bleeding.
    • Bleeding is particularly common in perimenopausal women.
  • Infertility:
    • Polyps may impair fertility by obstructing sperm pathways, affecting embryo implantation, or reducing uterine receptivity.
    • Polypectomy (surgical removal) has been shown to improve conception rates in women with infertility.
  • Asymptomatic:
    • Many polyps are incidentally found during routine imaging or evaluations for other complaints.
Diagnosis
  • Clinical Evaluation:
    • History of abnormal bleeding patterns or infertility may indicate the presence of polyps.
    • Physical exam is typically unremarkable unless polyps are large or prolapsed through the cervix.
  • Imaging:
    • Transvaginal Ultrasound (TVUS): First-line imaging tool that reveals polyps as focal endometrial thickenings or masses within the uterine cavity.
    • Saline Infusion Sonohysterography (SIS): Saline infusion into the uterine cavity during ultrasound enhances visualization, especially for smaller polyps.
  • Hysteroscopy:
    • Gold standard for diagnosis, allowing direct visualization and biopsy.
    • Enables concurrent polypectomy for symptomatic or suspicious polyps.
Differential Diagnosis
  • Leiomyomas (Fibroids): Uterine smooth muscle tumors that also cause abnormal bleeding, often differentiated by ultrasound.
  • Endometrial Hyperplasia: Diffuse endometrial thickening, which can appear similar to polyps but may show a more generalized pattern.
  • Endometrial Cancer: Must be ruled out in postmenopausal women with abnormal bleeding; biopsy is often required.
Management
  • Observation:
    • Small, asymptomatic polyps in premenopausal women may be monitored, as they can regress spontaneously.
  • Medical Management:
    • Hormonal Therapy: Oral contraceptives or progestins may help manage associated bleeding but do not eliminate polyps.
    • Limited effectiveness for definitive treatment, often reserved for bleeding control.
  • Surgical Treatment:
    • Hysteroscopic Polypectomy: Recommended for symptomatic polyps, large polyps, or in cases of infertility. Allows complete removal with minimal risk and is effective for symptom relief.
    • Polypectomy in Postmenopausal Women: Highly recommended due to the small but increased risk of malignancy.
Key Points
  • Uterine Polyps are benign endometrial overgrowths that project into the uterine cavity, commonly causing abnormal uterine bleeding and infertility.
  • Pathophysiology involves estrogen-dependent hyperplasia of endometrial glands, often with underlying genetic alterations.
  • Risk Factors: Perimenopausal age, obesity, unopposed estrogen or tamoxifen therapy, and hypertension.
  • Symptoms: Abnormal uterine bleeding (intermenstrual, menorrhagia, postmenopausal) and, less commonly, infertility. Many polyps are asymptomatic.
  • Diagnosis: Typically involves transvaginal ultrasound, with saline infusion sonohysterography enhancing visualization. Hysteroscopy is the gold standard for confirmation and treatment.
  • Management:
    • Observation for small, asymptomatic polyps in premenopausal women.
    • Hysteroscopic Polypectomy for symptomatic, large, or suspicious polyps, especially in postmenopausal women.
  • Complications: Although rare, malignancy can occur, particularly in postmenopausal women, making removal and histopathologic examination essential in these cases.